Study on protocol of Traditional Chinese medicine which aim directly at influencing factor in treating chronic aplastic anemia

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-11001712

Enrollment

Unknown

Registered

2011-11-15

Start date

2011-10-15

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic aplastic anemia

Interventions

treating group:Traditional Chinese medicine granules

treating group:androgen

control group:placebo

Eligibility

Sex/Gender

All

Age

14 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. diagnosed as chronic aplastic anemia, meanwhile, absolute neutrophil count >0.5*10^9/L, platelet >20.0*10^9/L; 2. >14 years old; 3. not take part in other research simultaneously.

Exclusion criteria

Exclusion criteria: 1. Other disease which may cause Pancytopenia, such as paroxysmal nocturnal hemoglobinuria, myelodysplastic syndrome, bone marrow fibrosis, acute leukemia, etc; 2. severe aplastic anemia, congenital aplastic anemia; 3. with severe diseases of heart, brain,liver, kidney, or mental disorder; 4. woman with pregnancy or lactation; 5. take part in other research simultaneously.

Design outcomes

Primary

Measure	Time frame
Accumulative incidence of infection;	—

Secondary

Measure	Time frame
Viral Antibodies;Blood routine test;Signs and symptoms of TCM;Immunal status;Quality of life;	—

Countries

China

Contacts

Public ContactZhou yuhong

zyhblood@163.com+86 13588887286

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026